Leonteq Securities’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Leonteq Securities's BMY Position: Q3 2026 in Review
Leonteq Securities reduced its Bristol-Myers Squibb (BMY) stake by 12% in Q3 2026, selling an estimated $92K and leaving 11,173 shares worth $697K. The position accounts for 0.03% of the portfolio, ranked #290.
Leonteq Securities first reported a position in BMY in Q1 2021 and has held it in 20 quarters since. The position peaked at $6.83M in Q1 2026. 2,555 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Leonteq Securities held 11,173 shares of Bristol-Myers Squibb worth $697K as of Q3 2026.
- Leonteq Securities sold 1,455 Bristol-Myers Squibb shares in Q3 2026, an estimated $92K.
- Bristol-Myers Squibb made up 0.03% of Leonteq Securities's portfolio in Q3 2026, its #290 holding.
- Leonteq Securities first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 20 quarters since.
- Leonteq Securities's Bristol-Myers Squibb position peaked at $6.83M in Q1 2026.
- 2,555 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.